Our People

our people

Health Trust_Header_900x390_People

The Alimentiv HealthTrust is governed by no less than five trustees. The group includes an active executive of a Trust enterprise, a lawyer, accountant or trust officer, a former employee and medical doctors with an academic appointment at a university. It is the fiduciary responsibility of the Trustees to carry out their obligations honestly, in good faith and in the best interests of the Trust and the beneficiaries. Trustees are tasked with upholding the Trust mandate to focus us in areas of interest to human health and the creation and retention of highly skilled jobs and employees locally, nationally and globally.

Dot

Trustees

Margaret (Peggy) Vandervoort

BSN, MSc

Margaret (Peggy) Vandervoort

BSN, MSc

Peggy Vandervoort previously worked at Alimentiv Clinical Trials from 1997 to 2016.

During her tenure, Peggy served in several management roles within Clinical Operations. She demonstrated success in developing and directing functional and project teams in achieving results, and in facilitating collaborations among Sponsor global teams, service providers and Alimentiv team members in meeting project goals. While Director of Clinical Operations, Peggy was a key member of the leadership team that led the expansion of the group to offices in California and The Netherlands.

Peggy earned her nursing degree from Queen’s University, and has a Graduate degree in Epidemiology and Biostatistics from McMaster University.


Ross Feldman

MD, FACP, FAHA, FRCPC

Ross Feldman

MD, FACP, FAHA, FRCPC

Dr. Ross Feldman is Medical Director, Cardiac Sciences Program for the Winnipeg Regional Health Authority, in addition he is also Professor of Medicine at the University of Manitoba.

He was just recently the Chair of Medicine at Memorial University of Newfoundland, St. John’s Newfoundland & Labrador, Canada. He is the author of more than 200 original manuscripts, reviews and book chapters. His clinical research program centers on the development of new approaches to the management of hypertension and specifically the development of innovative strategies to improve blood pressure control.

A major focus of his efforts has been in the prevention and control of hypertension in Canada and specifically in the knowledge translation of optimal treatment approaches for hypertension management. Among past leadership positions, Dr. Feldman served as the first Chair of the Steering Committee of the Canadian Hypertension Education Program, the organization that since 1999 has produced, disseminated and implemented annually updated guidelines for management of hypertension. As well, he served as President of the Canadian Hypertension Society. He was also the founding President of Hypertension Canada- leading the process of integrating the efforts of the Canadian Hypertension Society, Canadian Hypertension Education Program and Blood Pressure Canada.

He has received a number of awards and scholarships in recognition of his contributions in research, teaching and for his efforts in the prevention and control of hypertension in Canada. These include the George Morris Piersol Research and Teaching Scholarship from the American College of Physicians, a Career Investigator Award from the Heart and Stroke Foundation of Ontario, the Burroughs-Wellcome Clinical Pharmacology Award and the Senior Investigator Award from the Canadian Society for Clinical Pharmacology as well as the Distinguished Service/Research Award of the Canadian Hypertension Society. He also the recipient of the George Fodor Award from Hypertension Canada for outstanding contributions to the prevention and control of hypertension.


Paul Knill

LLB, ICD.D

Paul Knill

LLB, ICD.D

Paul Knill earned his law degree from Western University, and is a graduate of the Institute of Corporate Directors, Rotman School of Management.

Paul served as Managing Partner at the Canadian Law Firm, Siskinds LLP, during a period of significant expansion and change. His leadership encouraged innovative gathering and sharing of intellectual capital among business unit members. Paul went on to serve as an adjunct professor at Western University law school, and he currently contributes his corporate governance expertise by serving on the boards of a diverse number of Corporations.



Margaret (Peggy) Vandervoort

BSN, MSc

Peggy Vandervoort previously worked at Alimentiv Clinical Trials from 1997 to 2016.

During her tenure, Peggy served in several management roles within Clinical Operations. She demonstrated success in developing and directing functional and project teams in achieving results, and in facilitating collaborations among Sponsor global teams, service providers and Alimentiv team members in meeting project goals. While Director of Clinical Operations, Peggy was a key member of the leadership team that led the expansion of the group to offices in California and The Netherlands.

Peggy earned her nursing degree from Queen’s University, and has a Graduate degree in Epidemiology and Biostatistics from McMaster University.



Ross Feldman

MD, FACP, FAHA, FRCPC

Dr. Ross Feldman is Medical Director, Cardiac Sciences Program for the Winnipeg Regional Health Authority, in addition he is also Professor of Medicine at the University of Manitoba.

He was just recently the Chair of Medicine at Memorial University of Newfoundland, St. John’s Newfoundland & Labrador, Canada. He is the author of more than 200 original manuscripts, reviews and book chapters. His clinical research program centers on the development of new approaches to the management of hypertension and specifically the development of innovative strategies to improve blood pressure control.

A major focus of his efforts has been in the prevention and control of hypertension in Canada and specifically in the knowledge translation of optimal treatment approaches for hypertension management. Among past leadership positions, Dr. Feldman served as the first Chair of the Steering Committee of the Canadian Hypertension Education Program, the organization that since 1999 has produced, disseminated and implemented annually updated guidelines for management of hypertension. As well, he served as President of the Canadian Hypertension Society. He was also the founding President of Hypertension Canada- leading the process of integrating the efforts of the Canadian Hypertension Society, Canadian Hypertension Education Program and Blood Pressure Canada.

He has received a number of awards and scholarships in recognition of his contributions in research, teaching and for his efforts in the prevention and control of hypertension in Canada. These include the George Morris Piersol Research and Teaching Scholarship from the American College of Physicians, a Career Investigator Award from the Heart and Stroke Foundation of Ontario, the Burroughs-Wellcome Clinical Pharmacology Award and the Senior Investigator Award from the Canadian Society for Clinical Pharmacology as well as the Distinguished Service/Research Award of the Canadian Hypertension Society. He also the recipient of the George Fodor Award from Hypertension Canada for outstanding contributions to the prevention and control of hypertension.



Paul Knill

LLB, ICD.D

Paul Knill earned his law degree from Western University, and is a graduate of the Institute of Corporate Directors, Rotman School of Management.

Paul served as Managing Partner at the Canadian Law Firm, Siskinds LLP, during a period of significant expansion and change. His leadership encouraged innovative gathering and sharing of intellectual capital among business unit members. Paul went on to serve as an adjunct professor at Western University law school, and he currently contributes his corporate governance expertise by serving on the boards of a diverse number of Corporations.


Jeff Smith

Chief Executive Officer

Jeff Smith

Chief Executive Officer

Jeff has been the CEO at Alimentiv since October 2016. In May 2018, Jeff led the successful separation of the organization from its sole owner, Western University, to a Health Trust establishing the first social enterprise of its kind in North America.

 

Background

Jeff has a strong record of leading high-performing global teams that support the growth of global business units. His background in clinical research spans more than 20 years in the pharma and contract research organization (CRO) industries. Prior to his current position, he held senior positions with Alimentiv (formerly Robarts Clinical Trials) including Vice President, Clinical Operations and Director, Business Development. And before joining Alimentiv he was a Senior Director, General Medicine & Vaccines/Infectious Disease with PharmaNet (now Syneos). Jeff trained as a registered nurse, and holds a Bachelor Degree in Health Sciences (nursing).

 

Achievements

Jeff’s perspective on building a great company has been shaped from his experience working in a variety of ownership structures including government, private, public, private equity and venture capital. These experiences helped shape his vision for building a 100-year private company that pursues its purpose and putting people first ahead of shareholder returns. In May 2018, he was able to realize this vision with the transition of ownership of Robarts Clinical Trials to a Health Trust.

 

Ethos

“When leaders prioritize goodness in themselves and in others, they can create lasting cultures and tremendous value.”



Jeff Smith

Chief Executive Officer

Jeff has been the CEO at Alimentiv since October 2016. In May 2018, Jeff led the successful separation of the organization from its sole owner, Western University, to a Health Trust establishing the first social enterprise of its kind in North America.

 

Background

Jeff has a strong record of leading high-performing global teams that support the growth of global business units. His background in clinical research spans more than 20 years in the pharma and contract research organization (CRO) industries. Prior to his current position, he held senior positions with Alimentiv (formerly Robarts Clinical Trials) including Vice President, Clinical Operations and Director, Business Development. And before joining Alimentiv he was a Senior Director, General Medicine & Vaccines/Infectious Disease with PharmaNet (now Syneos). Jeff trained as a registered nurse, and holds a Bachelor Degree in Health Sciences (nursing).

 

Achievements

Jeff’s perspective on building a great company has been shaped from his experience working in a variety of ownership structures including government, private, public, private equity and venture capital. These experiences helped shape his vision for building a 100-year private company that pursues its purpose and putting people first ahead of shareholder returns. In May 2018, he was able to realize this vision with the transition of ownership of Robarts Clinical Trials to a Health Trust.

 

Ethos

“When leaders prioritize goodness in themselves and in others, they can create lasting cultures and tremendous value.”


Reflections from Trustee Peggy Vandervoort:

My heartfelt congratulations to all as you launch the new brand!  The symbolism of the olive tree in the Alimentiv logo resonates deeply as I reflect on the evolution of the group. I joined Brian Feagan (Director) and Cindy Wong (Deputy-Director) in 1997 and provided many years of support for the clinical operations team.

Brian and Cindy’s goals were firmly established from the start; to address therapeutic needs of patients, do great science and foster engagement of our staff.   As the tree grew stronger with deeper roots and new branches, we realized that several ‘nutrients’ were needed.  Larger teams of talented and skilled people provided with the resources required for their roles, innovative solutions to address unmet research needs and the investment of profits in research and development were required.

The team accomplished many firsts under Brian and Cindy’s leadership such as our first full-service trial, first global trial, first randomized evaluation of a care-path and first trial incorporating optimized, centrally read endoscopic and histopathologic outcome scores, to name a few.  I am very grateful to the loyal sponsors, clinical site teams and consultants who have partnered with us over the years.  New outcome measures and therapies, high impact publications and lasting bonds of friendship have been the result!

I fast forward to today, in awe that the group I joined with less than a dozen staff in the 1990’s currently has a growing global presence and over 300 employees.  Now retired, I am grateful for the opportunity to continue my association as a Trustee of the organization. I wish the newly branded Alimentiv team continuing success as they respond to emerging needs for heath care innovation.